VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
RAPP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
RAPPRapport Therapeutics, Inc. Common Stock
$24.82$1.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksRAPPQuarterly Cash Flow

Rapport Therapeutics, Inc. Common Stock (RAPP) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Rapport Therapeutics, Inc. Common Stock (RAPP) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

RAPP Cash Flow Statement

Quarterly statement

RAPP Cash Flow Statement

Rapport Therapeutics, Inc. Common Stock (RAPP) cash flow statement — 4-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Cash from Operations-41.63M-41.45M-13.06M-24.7M-17.46M-25.07M-20.24M-14.45M-16.41M-16.35M-17.61M-10.36M
Operating CF Margin %---65.31%---------
Operating CF Growth %-138.38%-65.36%35.46%-70.99%-6.4%-53.31%-14.89%-39.48%----
Net Income-40.23M-56.62M-19.86M-33.76M-26.93M-26.73M-24.06M-19.98M-17.54M-18.12M-22.67M-13.52M
Depreciation & Amortization198K212K227K265K256K252K244K260K219K208K152K53K
Stock-Based Compensation7.63M7.2M6.96M5.69M4.74M4.39M4.04M3.21M3.18M2.35M1.49M998K
Deferred Taxes000000000000
Other Non-Cash Items242K-728K371K-501K771K391K-25K725K-5.56M-670K6.57M167K
Working Capital Changes-9.47M8.47M-765K3.61M3.7M-3.37M-433K1.34M3.28M-123K-3.16M1.94M
Change in Receivables122K-235K-58K000000000
Change in Inventory000000000000
Change in Payables-1.09M-3.68M2.31M1.18M-179K1.03M185K648K46K94K-1.13M725K
Cash from Investing51.06M25.6M37.94M-174.32M-56.78M22.6M21.03M31.93M-53.04M-107.1M-41.93M-78.66M
Capital Expenditures0-78K-86K-169K-134K-22K-291K-226K-140K-967K-1.07M-1.44M
CapEx % of Revenue--0.43%---------
Acquisitions000000000000
Investments------------
Other Investing208K193K00092K436K03.77M000
Cash from Financing1.71M1.41M531K311K270.53M-63K5K7K-1.39M159.35M63.66M-140K
Debt Issued (Net)000000000000
Equity Issued (Net)1.71M1.59M804K311K270.47M-63K5K7K-1.39M159.07M63.94M-6K
Dividends Paid000000000000
Share Repurchases00-5K000-1K00000
Other Financing1K-181K-273K063K0000283K-283K-134K
Net Change in Cash11.14M-14.44M25.41M-198.71M196.29M-2.54M799K17.49M-70.85M35.9M4.12M-89.16M
Free Cash Flow-41.63M-41.53M-13.15M-24.87M-17.6M-25.09M-20.53M-14.67M-16.55M-17.32M-18.69M-11.79M
FCF Margin %---65.73%---------
FCF Growth %-136.56%-65.52%35.96%-69.51%-6.31%-44.88%-9.85%-24.4%----
FCF per Share-0.87-0.87-0.28-0.53-0.46-0.71-0.58-0.42-0.86-0.86-0.96-0.65
FCF Conversion (FCF/Net Income)1.03x0.73x0.66x0.73x0.65x0.94x0.84x0.72x0.94x0.90x0.78x0.77x
Interest Paid000000000000
Taxes Paid000000000000